Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.52 is 97% above its 5-year average of -84.63, near the high end of its 5-year range (-355.68–0.56).
41.05% above its 12-month average of -4.28.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.20.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 17 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:41:28.287Z. Historical observations retain their original dates. Historical series through 2021-08-16.
EARNINGS PER SHARE (EPS)
-2.52
EARNINGS PER SHARE (EPS) AVG TTM
-4.28
EARNINGS PER SHARE (EPS) AVG 3Y
-38.17
EARNINGS PER SHARE (EPS) AVG 5Y
-84.63
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+41.05%
CURRENT VS 3Y AVG
+93.40%
CURRENT VS 5Y AVG
+97.02%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Ensysce Biosciences, Inc.
Market Cap
$6.44M
Earnings Per Share (EPS)
-2.52
TTM Avg
-4.28
3Y Avg
-38.17
5Y Avg
-84.63
Market Cap
$6.34M
Earnings Per Share (EPS)
-1.26
TTM Avg
-1.73
3Y Avg
-1.08
5Y Avg
-0.87
Market Cap
$6.72M
Earnings Per Share (EPS)
-16.00
TTM Avg
-9.75
3Y Avg
-5.91
5Y Avg
-4.74
Market Cap
$6.74M
Earnings Per Share (EPS)
-7.60
TTM Avg
-3746.91
3Y Avg
-66167.96
5Y Avg
-82548.30
Market Cap
$6.76M
Earnings Per Share (EPS)
-16.46
TTM Avg
-132.36
3Y Avg
-129.45
5Y Avg
-404.68
Market Cap
$6.10M
Earnings Per Share (EPS)
-4.57
TTM Avg
-13.10
3Y Avg
-16.05
5Y Avg
-14.80
Market Cap
$6.10M
Earnings Per Share (EPS)
-2.92
TTM Avg
-6.51
3Y Avg
-19.53
5Y Avg
-13.36
Market Cap
$6.09M
Earnings Per Share (EPS)
537.52
TTM Avg
197.33
3Y Avg
123.75
5Y Avg
69.48
Market Cap
$6.03M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.92
3Y Avg
-0.62
5Y Avg
-0.53
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ensysce Biosciences, Inc. (ENSC) | $6.44M | -2.52 | -4.28 | -38.17 | -84.63 |
| Biomerica, Inc. (BMRA)vs › | $6.34M | -1.26 | -1.73 | -1.08 | -0.87 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -16.00 | -9.75 | -5.91 | -4.74 |
| Aclarion, Inc. (ACON)vs › | $6.74M | -7.60 | -3746.91 | -66167.96 | -82548.30 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | -16.46 | -132.36 | -129.45 | -404.68 |
| Femasys Inc. (FEMY)vs › | $6.10M | -4.57 | -13.10 | -16.05 | -14.80 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -2.92 | -6.51 | -19.53 | -13.36 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 537.52 | 197.33 | 123.75 | 69.48 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | N/A | -0.92 | -0.62 | -0.53 |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -26.72 | -36.23 | -30.51 | -16.78 |
Trailing EPS (TTM)
$-2.52
Forward EPS (Est.)
$-1.09
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.98 |
| 2024-12-31 | -4.57 |
| 2023-12-31 | -4.69 |
| 2022-12-31 | -139.44 |
| 2021-12-31 | -355.68 |
| 2020-12-31 | 0.56 |
| 2019-12-31 | -1.66 |
| 2018-12-31 | -0.22 |
| 2017-12-31 | -0.01 |
